Portfolio Design Labs’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Sell
8,002
-16,978
-68% -$922K 0.06% 180
2026
Q1
$1.57M Sell
24,980
-962
-4% -$77K 0.28% 71
2025
Q4
$2.47M Sell
25,942
-5,884
-18% -$577K 0.41% 52
2025
Q3
$3.11M Sell
31,826
-5,866
-16% -$607K 0.53% 33
2025
Q2
$4.05M Sell
37,692
-5,592
-13% -$566K 0.79% 32
2025
Q1
$4.37M Buy
43,284
+32,373
+297% +$3.26M 0.9% 27
2024
Q4
$975K Buy
+10,911
New +$961K 0.2% 103

Other funds holding BSX

Portfolio Design Labs's BSX Position: Q2 2026 in Review

Portfolio Design Labs reduced its Boston Scientific (BSX) stake by 68% in Q2 2026, selling an estimated $922K and leaving 8,002 shares worth $342K. The position accounts for 0.06% of the portfolio, ranked #180.

Portfolio Design Labs first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.37M in Q1 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Portfolio Design Labs held 8,002 shares of Boston Scientific worth $342K as of Q2 2026.
  • Portfolio Design Labs sold 16,978 Boston Scientific shares in Q2 2026, an estimated $922K.
  • Boston Scientific made up 0.06% of Portfolio Design Labs's portfolio in Q2 2026, its #180 holding.
  • Portfolio Design Labs first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Portfolio Design Labs's Boston Scientific position peaked at $4.37M in Q1 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.